Investor Update

Basel, 06 December 2018

Chugai Presents Interim Analysis Data of Phase I/II Study of SKY59, anti-C5 antibody in PNH at ASH

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.